A detailed history of Bahl & Gaynor Inc transactions in Resmed Inc stock. As of the latest transaction made, Bahl & Gaynor Inc holds 42,024 shares of RMD stock, worth $7.96 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
42,024
Previous 42,675 1.53%
Holding current value
$7.96 Million
Previous $7.34 Million 13.38%
% of portfolio
0.05%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$165.79 - $198.03 $107,929 - $128,917
-651 Reduced 1.53%
42,024 $8.32 Million
Q4 2023

Feb 02, 2024

SELL
$134.65 - $174.81 $78,366 - $101,739
-582 Reduced 1.35%
42,675 $7.34 Million
Q3 2023

Nov 03, 2023

SELL
$136.29 - $225.35 $181,265 - $299,715
-1,330 Reduced 2.98%
43,257 $6.4 Million
Q2 2023

Aug 14, 2023

SELL
$209.98 - $240.96 $417,440 - $479,028
-1,988 Reduced 4.27%
44,587 $9.74 Million
Q1 2023

May 03, 2023

SELL
$205.07 - $236.53 $137,807 - $158,948
-672 Reduced 1.42%
46,575 $10.2 Million
Q4 2022

Feb 10, 2023

SELL
$205.77 - $232.9 $171,817 - $194,471
-835 Reduced 1.74%
47,247 $9.83 Million
Q3 2022

Nov 14, 2022

SELL
$213.69 - $243.58 $197,876 - $225,555
-926 Reduced 1.89%
48,082 $10.5 Million
Q2 2022

Aug 08, 2022

SELL
$191.41 - $252.08 $104,509 - $137,635
-546 Reduced 1.1%
49,008 $10.3 Million
Q1 2022

May 12, 2022

SELL
$216.12 - $261.47 $19,883 - $24,055
-92 Reduced 0.19%
49,554 $12 Million
Q4 2021

Feb 10, 2022

SELL
$248.03 - $268.66 $345,257 - $373,974
-1,392 Reduced 2.73%
49,646 $12.9 Million
Q3 2021

Nov 15, 2021

SELL
$247.68 - $297.36 $1.41 Million - $1.69 Million
-5,681 Reduced 10.02%
51,038 $13.5 Million
Q2 2021

Aug 06, 2021

SELL
$187.97 - $247.09 $75,000 - $98,588
-399 Reduced 0.7%
56,719 $14 Million
Q1 2021

May 11, 2021

SELL
$179.46 - $222.28 $604,959 - $749,305
-3,371 Reduced 5.57%
57,118 $11.1 Million
Q4 2020

Feb 02, 2021

SELL
$167.5 - $220.59 $119,762 - $157,721
-715 Reduced 1.17%
60,489 $12.9 Million
Q3 2020

Nov 12, 2020

SELL
$168.14 - $205.63 $335,439 - $410,231
-1,995 Reduced 3.16%
61,204 $10.5 Million
Q2 2020

Aug 13, 2020

BUY
$142.29 - $192.0 $45,532 - $61,440
320 Added 0.51%
63,199 $12.1 Million
Q1 2020

May 26, 2020

BUY
$114.34 - $176.62 $7.19 Million - $11.1 Million
62,879 New
62,879 $9.26 Million
Q1 2020

May 15, 2020

SELL
$114.34 - $176.62 $7.03 Million - $10.9 Million
-61,492 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$126.52 - $156.7 $262,655 - $325,309
-2,076 Reduced 3.27%
61,492 $9.53 Million
Q3 2019

Nov 14, 2019

SELL
$123.37 - $140.33 $73,405 - $83,496
-595 Reduced 0.93%
63,568 $8.59 Million
Q2 2019

Aug 12, 2019

SELL
$97.37 - $123.27 $1.42 Million - $1.8 Million
-14,627 Reduced 18.56%
64,163 $7.83 Million
Q1 2019

May 13, 2019

BUY
$91.56 - $117.84 $448,918 - $577,769
4,903 Added 6.64%
78,790 $8.19 Million
Q4 2018

Feb 12, 2019

SELL
$98.06 - $115.33 $1.07 Million - $1.25 Million
-10,869 Reduced 12.82%
73,887 $8.41 Million
Q3 2018

Nov 09, 2018

SELL
$103.52 - $115.55 $651,658 - $727,387
-6,295 Reduced 6.91%
84,756 $9.78 Million
Q2 2018

Aug 14, 2018

SELL
$93.62 - $107.93 $323,082 - $372,466
-3,451 Reduced 3.65%
91,051 $9.43 Million
Q1 2018

May 11, 2018

SELL
$85.53 - $102.82 $8.41 Million - $10.1 Million
-98,278 Reduced 50.98%
94,502 $9.31 Million
Q4 2017

Feb 13, 2018

SELL
$76.14 - $86.44 $112,154 - $127,326
-1,473 Reduced 0.76%
192,780 $16.3 Million
Q3 2017

Nov 13, 2017

BUY
$76.11 - $77.2 $198,266 - $201,106
2,605 Added 1.36%
194,253 $15 Million
Q2 2017

Aug 11, 2017

BUY
N/A
4,790 Added 2.56%
191,648 $14.9 Million
Q2 2017

Aug 10, 2017

BUY
N/A
186,858
186,858 $11.6 Million

Others Institutions Holding RMD

About RESMED INC


  • Ticker RMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 146,459,008
  • Market Cap $27.7B
More about RMD
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.